These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 7155941)

  • 21. Pharmacologic management of patent ductus arteriosus.
    Bhatt V; Nahata MC
    Clin Pharm; 1989 Jan; 8(1):17-33. PubMed ID: 2643499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Patency of ductus arteriosus in the premature newborn infant: diagnosis, complications, treatment].
    Agnetti A; Viola P; Zavota L; De Luca F; Squarcia U
    Pediatr Med Chir; 1984; 6(5):609-15. PubMed ID: 6535121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patent ductus arteriosus in the newborn.
    Archer N
    Arch Dis Child; 1993 Nov; 69(5 Spec No):529-32. PubMed ID: 8285761
    [No Abstract]   [Full Text] [Related]  

  • 24. [An alternative in the management of patent ductus arteriosus using indomethacin in premature newborn infants].
    Lozano González CH; Holden AM; Hurtado del Río D; Segura MA
    Bol Med Hosp Infant Mex; 1982 Aug; 39(8):570-5. PubMed ID: 7182006
    [No Abstract]   [Full Text] [Related]  

  • 25. Asymptomatic reopening of ductus arteriosus after successful closure by indomethacin in premature infants.
    Yen SL; Teng RJ; Ho MM
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1993; 34(5):379-84. PubMed ID: 8237357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ibuprofen--a new application for pharmacological closure of patent ductus arteriosus in preterm infants. Preliminary report].
    Adamska E
    Med Wieku Rozwoj; 2000; 4(2 Suppl 3):65-71. PubMed ID: 11328971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Closure of persistent ductus arteriosus in premature infants by drug therapy].
    Hencz P; Kertész E; Beviz J; Szeleczki T; Szekeres Z
    Orv Hetil; 1981 Oct; 122(41):2535-40. PubMed ID: 7033879
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacologic closure of patent ductus arteriosus in the premature infant.
    Friedman WF; Hirschklau MJ; Printz MP; Pitlick PT; Kirkpatrick SE
    N Engl J Med; 1976 Sep; 295(10):526-9. PubMed ID: 820994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and clinical efficacy of indomethacin in premature infants with patent ductus arteriosus.
    Regazzi MB; Rondanelli R; Vidale E; Chirico G; Rondini G; Chiara A; Piccolo A
    Int J Clin Pharmacol Res; 1984; 4(2):109-12. PubMed ID: 6469435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical closure of patent ductus arteriosus in 268 preterm infants.
    Wagner HR; Ellison RC; Zierler S; Lang P; Purohit DM; Behrendt D; Waldhausen JA
    J Thorac Cardiovasc Surg; 1984 Jun; 87(6):870-5. PubMed ID: 6374300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indomethacin therapy in premature infants with patent ductus arteriosus and oliguria.
    Yeh TF; Wilks A; Luken J; Pildes RS
    Dev Pharmacol Ther; 1986; 9(6):369-74. PubMed ID: 3816491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
    Jaillard S; Larrue B; Rakza T; Magnenant E; Warembourg H; Storme L
    Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study.
    Yanagi RM; Wilson A; Newfeld EA; Aziz KU; Hunt CE
    Pediatrics; 1981 May; 67(5):647-52. PubMed ID: 7019841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneous closure of the patent ductus arteriosus in very low birth weight infants following discharge from the neonatal unit.
    Herrman K; Bose C; Lewis K; Laughon M
    Arch Dis Child Fetal Neonatal Ed; 2009 Jan; 94(1):F48-50. PubMed ID: 18450808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of patent ductus arteriosus in preterm infants].
    Jaso E; Tejedor JC; Quero J; Pérez Rodríguez J; Agustí B; Castro J; García Frías E
    An Esp Pediatr; 1982 Jun; 16(6):449-58. PubMed ID: 7125398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic closure of the ductus arteriosus: benefits and limitations.
    Mercanti I; Boubred F; Simeoni U
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():14-20. PubMed ID: 19925358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of patent ductus arteriosus in premature infants by indomethacin].
    Monin P; Bianchetti G; Marchal F; Vert P; Morselli P
    Presse Med; 1987 Jun; 16(21):1035-8. PubMed ID: 2955324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variation and comparative effectiveness of patent ductus arteriosus pharmacotherapy in extremely low birth weight infants.
    ElHassan NO; Bird TM; King AJ; Ambadwar PB; Jaquiss RD; Kaiser JR; Robbins JM
    J Neonatal Perinatal Med; 2014 Jan; 7(3):229-35. PubMed ID: 25322995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patent ductus arteriosus in preterm infants.
    Yu VY
    Med J Aust; 1980 Aug; 2(4):175-6. PubMed ID: 7432277
    [No Abstract]   [Full Text] [Related]  

  • 40. Sepsis and indomethacin failure in premature infants with symptomatic patent ductus arteriosus.
    Salzer HR; Salzer-Muhar U; Pollak A; Weninger M
    Lancet; 1987 Apr; 1(8539):977. PubMed ID: 2882363
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.